|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
44,800,000 |
Market
Cap: |
168.90(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.4 - $9.48 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Kodiak Sciences is a biopharmaceutical company focused on researching, developing and commercializing therapeutics to treat high prevalence retinal diseases. Co.'s Antibody Biopolymer Conjugate Platform uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies. Co.'s main product candidate, KSI-301, is an anti-vascular endothelial growth factor antibody biopolymer conjugate for the treatment in retinal vascular diseases including wet age-related macular degeneration (AMD), diabetic macular edema and retinal vein occlusion. Co.'s pipeline, including product candidates KSI-501 and KSI-601, are used for other needs in retina such as dry AMD and glaucoma.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,379,445 |
Total Buy Value |
$0 |
$0 |
$0 |
$9,508,745 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
9 |
Total Shares Sold |
0 |
0 |
7,587 |
15,417 |
Total Sell Value |
$0 |
$0 |
$70,517 |
$126,006 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
4 |
8 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Ehrlich Jason |
See Remarks |
|
2021-05-12 |
4 |
OE |
$10.00 |
$74,240 |
D/D |
7,268 |
70,111 |
|
- |
|
Ehrlich Jason |
See Remarks |
|
2021-04-20 |
4 |
AS |
$109.33 |
$773,249 |
D/D |
(6,950) |
62,843 |
|
-14% |
|
Ehrlich Jason |
See Remarks |
|
2021-04-20 |
4 |
OE |
$10.29 |
$71,516 |
D/D |
6,950 |
69,793 |
|
- |
|
Ehrlich Jason |
See Remarks |
|
2021-03-22 |
4 |
AS |
$130.49 |
$913,894 |
D/D |
(6,950) |
62,843 |
|
-36% |
|
Ehrlich Jason |
See Remarks |
|
2021-03-22 |
4 |
OE |
$10.29 |
$71,516 |
D/D |
6,950 |
69,793 |
|
- |
|
Borgeson John A. |
See Remarks |
|
2021-03-10 |
4 |
AS |
$127.08 |
$650,415 |
D/D |
(5,000) |
165,899 |
|
-32% |
|
Ehrlich Jason |
See Remarks |
|
2021-03-03 |
4 |
OE |
$10.29 |
$128,625 |
D/D |
12,500 |
62,843 |
|
- |
|
Ehrlich Jason |
See Remarks |
|
2021-02-22 |
4 |
AS |
$122.00 |
$874,367 |
D/D |
(6,950) |
50,343 |
|
-22% |
|
Ehrlich Jason |
See Remarks |
|
2021-02-22 |
4 |
OE |
$10.29 |
$71,516 |
D/D |
6,950 |
57,293 |
|
- |
|
Ehrlich Jason |
See Remarks |
|
2021-01-20 |
4 |
AS |
$159.96 |
$4,386,776 |
D/D |
(26,950) |
50,343 |
|
-50% |
|
Ehrlich Jason |
See Remarks |
|
2021-01-20 |
4 |
OE |
$10.29 |
$277,316 |
D/D |
26,950 |
77,293 |
|
- |
|
Ehrlich Jason |
See Remarks |
|
2020-12-23 |
4 |
OE |
$10.29 |
$77,175 |
D/D |
7,500 |
50,343 |
|
- |
|
Ehrlich Jason |
See Remarks |
|
2020-12-21 |
4 |
AS |
$139.29 |
$1,004,610 |
D/D |
(6,950) |
42,843 |
|
-22% |
|
Ehrlich Jason |
See Remarks |
|
2020-12-21 |
4 |
OE |
$10.29 |
$71,516 |
D/D |
6,950 |
49,793 |
|
- |
|
Ehrlich Jason |
See Remarks |
|
2020-11-20 |
4 |
AS |
$133.71 |
$964,601 |
D/D |
(6,950) |
42,843 |
|
-17% |
|
Ehrlich Jason |
See Remarks |
|
2020-11-20 |
4 |
OE |
$10.29 |
$71,516 |
D/D |
6,950 |
49,793 |
|
- |
|
Baker Julian |
Director |
|
2020-11-20 |
4 |
B |
$108.00 |
$164,999,916 |
I/I |
1,527,777 |
12,736,556 |
2.25 |
-17% |
|
Ehrlich Jason |
See Remarks |
|
2020-10-27 |
4 |
AS |
$100.00 |
$750,000 |
D/D |
(7,500) |
42,843 |
|
30% |
|
Ehrlich Jason |
See Remarks |
|
2020-10-27 |
4 |
OE |
$10.29 |
$77,175 |
D/D |
7,500 |
50,343 |
|
- |
|
Ehrlich Jason |
See Remarks |
|
2020-10-23 |
4 |
AS |
$86.25 |
$646,875 |
D/D |
(7,500) |
42,843 |
|
25% |
|
Ehrlich Jason |
See Remarks |
|
2020-10-23 |
4 |
OE |
$10.29 |
$77,175 |
D/D |
7,500 |
50,343 |
|
- |
|
Ehrlich Jason |
See Remarks |
|
2020-10-20 |
4 |
AS |
$76.53 |
$544,817 |
D/D |
(6,950) |
42,843 |
|
60% |
|
Ehrlich Jason |
See Remarks |
|
2020-10-20 |
4 |
OE |
$10.29 |
$71,516 |
D/D |
6,950 |
49,793 |
|
- |
|
Ehrlich Jason |
See Remarks |
|
2020-10-13 |
4 |
AS |
$75.00 |
$375,000 |
D/D |
(5,000) |
42,843 |
|
64% |
|
Ehrlich Jason |
See Remarks |
|
2020-10-13 |
4 |
OE |
$10.29 |
$51,450 |
D/D |
5,000 |
47,843 |
|
- |
|
98 Records found
|
|
Page 2 of 4 |
|
|